FDA Ad Division Urges Increase In Submissions Of Promotional Materials For Review
This article was originally published in The Pink Sheet Daily
CDER's Davis says issue is something that companies "need to work on." The agency is working to simplify the submission of promotional materials by creating an electronic process by year-end.
You may also be interested in...
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.
A draft agreement between industry and FDA that would assess user fees for "advisory review" of broadcast direct-to-consumer ads prior to initial public dissemination had its genesis in the Pharmaceutical Research & Manufacturers of America's DTC guiding principles
Sepracor's television ads for its sleep aid Lunesta create brand recognition better than other new prescription drug direct-to-consumer ads, according to an analysis performed by IAG Research